333 related articles for article (PubMed ID: 19220753)
61. Investigational drug therapies for the treatment of gastroparesis.
Sanger GJ; Pasricha PJ
Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
[TBL] [Abstract][Full Text] [Related]
62. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
Ejskjaer N; Vestergaard ET; Hellström PM; Gormsen LC; Madsbad S; Madsen JL; Jensen TA; Pezzullo JC; Christiansen JS; Shaughnessy L; Kosutic G
Aliment Pharmacol Ther; 2009 Jun; 29(11):1179-87. PubMed ID: 19298585
[TBL] [Abstract][Full Text] [Related]
63. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia.
Khoo J; Rayner CK; Feinle-Bisset C; Jones KL; Horowitz M
Neurogastroenterol Motil; 2010 Dec; 22(12):1270-8. PubMed ID: 20939851
[TBL] [Abstract][Full Text] [Related]
64. Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis.
Dhir R; Richter JE
J Clin Gastroenterol; 2004 Mar; 38(3):237-42. PubMed ID: 15128069
[TBL] [Abstract][Full Text] [Related]
65. Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test.
Lim CH; Choi MG; Park H; Baeg MK; Park JM
World J Gastroenterol; 2013 Jul; 19(27):4380-5. PubMed ID: 23885150
[TBL] [Abstract][Full Text] [Related]
66. Characterization of gastric volume responses and liquid emptying in functional dyspepsia and health by MRI or barostat and simultaneous C-acetate breath test.
Fruehauf H; Steingoetter A; Fox MR; Kwiatek MA; Boesiger P; Schwizer W; Fried M; Thumshirn M; Goetze O
Neurogastroenterol Motil; 2009 Jul; 21(7):697-e37. PubMed ID: 19368659
[TBL] [Abstract][Full Text] [Related]
67. [Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].
Raedsch R; Hanisch J; Bock P; Sibaev A; Vinson B; Gundermann KJ
Z Gastroenterol; 2007 Oct; 45(10):1041-8. PubMed ID: 17924300
[TBL] [Abstract][Full Text] [Related]
68. [Pathomechanisms of functional gastroparesis].
Sobocki J; Królczyk G; Thor PJ
Folia Med Cracov; 2006; 47(1-4):51-9. PubMed ID: 18038612
[TBL] [Abstract][Full Text] [Related]
69. Effect of a phyto-compound on delayed gastric emptying in functional dyspepsia: a randomized-controlled study.
Metugriachuk Y; Marotta F; Kuroi O; Tsuchiya J; Goh KL; Minelli E; Kawakita S
J Dig Dis; 2008 Nov; 9(4):204-7. PubMed ID: 18959591
[TBL] [Abstract][Full Text] [Related]
70. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men.
Pilichiewicz AN; Horowitz M; Russo A; Maddox AF; Jones KL; Schemann M; Holtmann G; Feinle-Bisset C
Am J Gastroenterol; 2007 Jun; 102(6):1276-83. PubMed ID: 17378904
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.
Zhang S; Zhao L; Wang H; Wang C; Huang S; Shen H; Wei W; Tao L; Zhou T
BMC Complement Altern Med; 2013 Mar; 13():54. PubMed ID: 23453018
[TBL] [Abstract][Full Text] [Related]
72. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.
Choung RS; Cremonini F; Thapa P; Zinsmeister AR; Talley NJ
Neurogastroenterol Motil; 2008 Mar; 20(3):220-7. PubMed ID: 18031471
[TBL] [Abstract][Full Text] [Related]
73. Gastric emptying before and after cholecystectomy in patients with cholecystolithiasis.
Vignolo MC; Savassi-Rocha PR; Coelho LG; Soares MP; Cardoso-Júnior A; Barbosa TF; Ramos FV; Alves TR; Barbosa GM; Pinto DC; Resende Cde C; Boechat Lde C; de Almeida AM
Hepatogastroenterology; 2008; 55(84):850-4. PubMed ID: 18705281
[TBL] [Abstract][Full Text] [Related]
74. What comes after macrolides and other motilin stimulants?
Tack J; Peeters T
Gut; 2001 Sep; 49(3):317-8. PubMed ID: 11511547
[No Abstract] [Full Text] [Related]
75. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.
Madisch A; Holtmann G; Mayr G; Vinson B; Hotz J
Digestion; 2004; 69(1):45-52. PubMed ID: 14755152
[TBL] [Abstract][Full Text] [Related]
76. Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis.
Bharucha AE; Daley SL; Low PA; Gibbons SJ; Choi KM; Camilleri M; Saw JJ; Farrugia G; Zinsmeister AR
Neurogastroenterol Motil; 2016 Nov; 28(11):1731-1740. PubMed ID: 27283929
[TBL] [Abstract][Full Text] [Related]
77. Spatial Patterns From High-Resolution Electrogastrography Correlate With Severity of Symptoms in Patients With Functional Dyspepsia and Gastroparesis.
Gharibans AA; Coleman TP; Mousa H; Kunkel DC
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2668-2677. PubMed ID: 31009794
[TBL] [Abstract][Full Text] [Related]
78. Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia.
Qiu XJ; Huang X; Chen ZQ; Ren P; Huang W; Qin F; Hu SH; Huang J; He J; Liu ZQ; Zhou HH
J Ethnopharmacol; 2011 Sep; 137(1):205-13. PubMed ID: 21605652
[TBL] [Abstract][Full Text] [Related]
79. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
[TBL] [Abstract][Full Text] [Related]
80. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.
Ottillinger B; Storr M; Malfertheiner P; Allescher HD
Wien Med Wochenschr; 2013 Feb; 163(3-4):65-72. PubMed ID: 23263639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
